MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience DSO Ratio 2011-2025 | HBIO
Annual DSO Ratio Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 | 62.1 | 60.8 | 63.5 | 65 | 74.3 | 73.3 | 69.6 | 71.9 | 70.1 | 61.3 | 62.3 | 58.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.3 | 53.3 | 65.1 |
Quarterly DSO Ratio Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 | 56.7 | 59.4 | - | 52.6 | 54.9 | 58.5 | - | 57.4 | 55 | 52.4 | - | - | 31.7 | 66.8 | - | 55 | 53.9 | 58.9 | - | 67.4 | 69.5 | 73.8 | 61 | 68.9 | 63.9 | 68.2 | 57.8 | 68.4 | 62.1 | 59.4 | 56.4 | 65.2 | 64.4 | 73.5 | 54.4 | 57.5 | 55 | 56.3 | 56.4 | 62.2 | 55.6 | 59.7 | 48.5 | 57.9 | 54.6 | 50.8 | 45.5 | 50.3 | 48.5 | 49.4 | 46.4 | 50.2 | 46 | 47.4 | 47.4 | 52.1 | 25.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 | 25.3 | 56.2 |
DSO Ratio of other stocks in the Medical instruments industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.29 | -0.41 % | $ 1.12 B |  USA |
 |
Baxter International
BAX
|
204 | $ 19.77 | 3.21 % | $ 10.1 B | USA |
 |
Becton, Dickinson and Company
BDX
|
50.4 | $ 200.24 | -0.32 % | $ 57.6 B | USA |
 |
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
26.4 | $ 148.24 | -0.13 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
43.6 | $ 171.44 | 1.55 % | $ 5.35 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
48.7 | $ 5.85 | 1.21 % | $ 267 M | USA |
 |
LeMaitre Vascular
LMAT
|
43.2 | $ 84.03 | 0.04 % | $ 1.89 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
131 | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Masimo Corporation
MASI
|
12.7 | $ 136.68 | -1.2 % | $ 7.29 B | USA |
 |
Merit Medical Systems
MMSI
|
49.5 | $ 86.04 | -0.76 % | $ 5.01 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
71 | $ 79.18 | 0.48 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
44.3 | $ 41.37 | -2.39 % | $ 1.94 B | USA |
 |
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M | USA |
 |
ResMed
RMD
|
60.7 | $ 253.22 | 0.38 % | $ 37 B | USA |
 |
electroCore
ECOR
|
12.7 | $ 4.81 | 1.23 % | $ 26.5 K | USA |
 |
AngioDynamics
ANGO
|
54 | $ 13.35 | 1.6 % | $ 545 M | USA |
 |
The Cooper Companies
COO
|
68.9 | $ 81.0 | -1.32 % | $ 16.1 B | USA |
 |
STAAR Surgical Company
STAA
|
100 | $ 23.62 | -2.11 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
68.6 | $ 252.38 | 0.23 % | $ 24.9 B | USA |
 |
Stereotaxis
STXS
|
60.8 | $ 2.37 | - | $ 191 M | USA |
 |
Glaukos Corporation
GKOS
|
44 | $ 112.03 | 2.89 % | $ 5.43 B | USA |
 |
Haemonetics Corporation
HAE
|
54.9 | $ 78.83 | -5.58 % | $ 3.97 B | USA |
 |
InfuSystem Holdings
INFU
|
53.6 | $ 9.18 | -0.65 % | $ 190 M | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Utah Medical Products
UTMD
|
132 | $ 58.21 | 0.19 % | $ 211 M | USA |
 |
Intuitive Surgical
ISRG
|
51.5 | $ 554.04 | 2.16 % | $ 197 B | USA |
 |
OraSure Technologies
OSUR
|
62.8 | $ 2.49 | -0.2 % | $ 185 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
64.3 | $ 11.4 | -1.47 % | $ 2.32 B | USA |
 |
Microbot Medical
MBOT
|
167 | $ 2.27 | -6.02 % | $ 23.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
16.7 | $ 0.37 | -5.1 % | $ 29.5 M | USA |
 |
Nephros
NEPH
|
35.7 | $ 4.96 | -1.29 % | $ 51.5 M | USA |
 |
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
56 | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
83.1 | $ 42.11 | -2.94 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
15.9 | $ 14.09 | -1.05 % | $ 677 M | USA |
 |
Predictive Oncology
POAI
|
115 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
69.4 | $ 158.06 | 0.43 % | $ 8.81 M | USA |
 |
Retractable Technologies
RVP
|
102 | $ 0.84 | 1.63 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
54.1 | $ 126.54 | -0.27 % | $ 5.93 B | USA |
 |
West Pharmaceutical Services
WST
|
67.1 | $ 269.57 | 0.76 % | $ 19.7 B | USA |